REAL-WORLD COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND USTEKINUMAB IN PATIENTS WITH ULCERATIVE COLITIS EXPOSED TO AT LEAST ONE ANTI-TNF AGENT: LONG-TERM RESULTS FROM THE TORUS STUDY

Anthony Buisson  ¹     Mélanie Serrero  ²     Romain Altwegg  ³     Thomas Guilmoteau  ³     Guillaume Bouguen  ⁴     Maria Nachury  ⁵     Aurelien Amiot  ⁶     Lucine Vuitton  ⁷     Xavier Treton  ⁸     Ludovic Caillo  ⁹     Bruno Pereira  ⁹     Mathurin Fumery  ^10    
1 CHU Estaing Clermont-Ferrand, Clermont-Ferrand, France
² Hopital Nord, Marseille, France
³ Hopital Saint Eloi Hepatologie Gastroenterologie, Montpellier, France
⁴ CHU Pontchaillou, Rennes, France
⁵ CHRU Lille, Lille, France
⁶ Kremlin-Bicetre, APHP Dept. of Gastroenterology, Le Kremlin Bicetre, France
⁷ Besançon University Hospital Gastroenterology, Besnaçon, France
⁸ Institut des MICI, Paris, France
⁹ CHU de Nimes, Nîmes, France
¹⁰ Amiens University Hospital, Amiens, France

Topic
IBD

Session
Sequential therapies in IBD: Raising the bar

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)